MedPath

REFLUDAN

REFLUDAN

Discontinued
DIN Number

02240996

Drug Class

Human

Market Date

Jan 31, 2000

Company
HC

Bayer Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02240996
AIG Number0138607001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B01AE02 LEPIRUDIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:12.04.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

LEPIRUDINActive
Strength: 50 MG / VIAL
Monograph: LEPIRUDIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.